Judy L. Chase

1.1k total citations
16 papers, 781 citations indexed

About

Judy L. Chase is a scholar working on Surgery, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, Judy L. Chase has authored 16 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 6 papers in Hepatology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Judy L. Chase's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Chemotherapy-induced organ toxicity mitigation (4 papers). Judy L. Chase is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Chemotherapy-induced organ toxicity mitigation (4 papers). Judy L. Chase collaborates with scholars based in United States, Switzerland and Italy. Judy L. Chase's co-authors include Mark S. Roh, Steven A. Curley, David C. Hohn, David C. Hohn, Robert Stagg, B.J. Lewis, Alan P. Venook, Ernest J. Ring, Yehuda Z. Patt and Timothy P. Maroney and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Judy L. Chase

16 papers receiving 766 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Judy L. Chase United States	13	455	390	304	135	97	16	781
Christian Grieser Germany	19	375 0.8×	441 1.1×	231 0.8×	222 1.6×	45 0.5×	56	987
Geert-Jan Creemers Netherlands	15	250 0.5×	489 1.3×	907 3.0×	376 2.8×	99 1.0×	44	1.4k
Jeffrey P. Meyers United States	17	207 0.5×	528 1.4×	863 2.8×	408 3.0×	122 1.3×	40	1.4k
Philippe Gertsch Switzerland	17	566 1.2×	1.1k 2.7×	522 1.7×	308 2.3×	55 0.6×	48	1.4k
Elizabeth Gleeson United States	16	110 0.2×	408 1.0×	296 1.0×	179 1.3×	117 1.2×	58	727
Geert‐Jan Creemers Netherlands	22	44 0.1×	394 1.0×	781 2.6×	329 2.4×	58 0.6×	65	1.2k
Roberto Luca Meniconi Italy	13	198 0.4×	315 0.8×	173 0.6×	141 1.0×	15 0.2×	44	510
Christine Rebischung France	16	107 0.2×	362 0.9×	570 1.9×	416 3.1×	30 0.3×	34	935
Claus Wilki Fristrup Denmark	19	147 0.3×	703 1.8×	489 1.6×	401 3.0×	116 1.2×	84	1.1k
Arben Lleshi Italy	18	131 0.3×	125 0.3×	420 1.4×	108 0.8×	10 0.1×	49	880

Countries citing papers authored by Judy L. Chase

Since Specialization

Citations

This map shows the geographic impact of Judy L. Chase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judy L. Chase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judy L. Chase more than expected).

Fields of papers citing papers by Judy L. Chase

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judy L. Chase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judy L. Chase. The network helps show where Judy L. Chase may publish in the future.

Co-authorship network of co-authors of Judy L. Chase

This figure shows the co-authorship network connecting the top 25 collaborators of Judy L. Chase. A scholar is included among the top collaborators of Judy L. Chase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judy L. Chase. Judy L. Chase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Lin, Heather, et al.. (2018). Impact of a pharmacy-driven transitions-of-care program on postdischarge healthcare utilization at a national comprehensive cancer center. American Journal of Health-System Pharmacy. 75(18). 1386–1393. 9 indexed citations

Goldspiel, Barry R., James M. Hoffman, Niesha Griffith, et al.. (2015). ASHP Guidelines on Preventing Medication Errors with Chemotherapy and Biotherapy. American Journal of Health-System Pharmacy. 72(8). e6–e35. 63 indexed citations

Chase, Judy L., Robert A. Wolff, Laura Lambert, et al.. (2009). Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal origin. Cancer. 116(2). 316–322. 89 indexed citations

Chase, Judy L.. (2008). Clinical Use of Anti‐Vascular Endothelial Growth Factor Monoclonal Antibodies in Metastatic Colorectal Cancer. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(11P2). 23S–30S. 23 indexed citations

Lim, Sherry J., Janice N. Cormier, Barry W. Feig, et al.. (2007). Toxicity and Outcomes Associated with Surgical Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients with Sarcomatosis. Annals of Surgical Oncology. 14(8). 2309–2318. 53 indexed citations

Scaife, Courtney L., Steven A. Curley, Francesco Izzo, et al.. (2003). Feasibility of Adjuvant Hepatic Arterial Infusion of Chemotherapy After Radiofrequency Ablation With or Without Resection in Patients With Hepatic Metastases From Colorectal Cancer. Annals of Surgical Oncology. 10(4). 348–354. 36 indexed citations

Meric, Funda, Yehuda Z. Patt, Judy L. Chase, et al.. (2000). Surgery After Downstaging of Unresectable Hepatic Tumors With Intra-Arterial Chemotherapy. Annals of Surgical Oncology. 7(7). 490–495. 82 indexed citations

Davidson, Bradley S., Francesco Izzo, Judy L. Chase, et al.. (1996). Alternating floxuridine and 5-fluorouracil hepatic arterial chemotherapy for colorectal liver metastases minimizes biliary toxicity. The American Journal of Surgery. 172(3). 244–247. 26 indexed citations

Curley, Steven A., Mark S. Roh, Judy L. Chase, & David C. Hohn. (1993). Adjuvant hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases. The American Journal of Surgery. 166(6). 743–748. 74 indexed citations

10.

Curley, Steven A., David R. Byrd, Robert A. Newman, et al.. (1993). Reduction of systemic drug exposure after hepatic arterial infusion of doxorubicin with complete hepatic venous isolation and extracorporeal chemofiltration.. PubMed. 114(3). 579–85. 23 indexed citations

11.

Curley, Steven A., Judy L. Chase, Mark S. Roh, & David C. Hohn. (1993). Technical considerations and complications associated with the placement of 180 implantable hepatic arterial infusion devices.. PubMed. 114(5). 928–35. 81 indexed citations

12.

Curley, Steven A., David R. Byrd, Robert A. Newman, et al.. (1991). Hepatic arterial infusion chemotherapy with complete hepatic venous isolation and extracorporeal chemofiltration. Anti-Cancer Drugs. 2(2). 175–184. 17 indexed citations

13.

Stagg, Robert, Alan P. Venook, Judy L. Chase, et al.. (1991). Alternating Hepatic Intra-Arterial Floxuridine and Fluorouracil: A Less Toxic Regimen for Treatment of Liver Metastases From Colorectal Cancer. JNCI Journal of the National Cancer Institute. 83(6). 423–428. 67 indexed citations

14.

Venook, Alan P., Robert Stagg, B.J. Lewis, et al.. (1990). Chemoembolization for hepatocellular carcinoma.. Journal of Clinical Oncology. 8(6). 1108–1114. 124 indexed citations

15.

Plezia, Patricia M., et al.. (1990). Randomized crossover comparison of high-dose intravenous metoclopramide versus a five-drug antiemetic regimen. Journal of Pain and Symptom Management. 5(2). 101–108. 2 indexed citations

16.

Keßler, J., David S. Alberts, Patricia M. Plezia, et al.. (1986). An effective five-drug antiemetic combination for prevention of chemotherapy-related nausea and vomiting. Cancer Chemotherapy and Pharmacology. 16(3). 282–286. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact